facebook tracking
knowledge-service-img

Regulation/Guidelines

Schedule M Revisions: How Will They Impact Pharmaceutical Manufacturers?

What a Revised Schedule M raises GMP standards in India, what has changed for manufacturers, and how large firms and MSMEs can prepare for Compliance and CDSCO inspections. Revised Schedule M is the biggest overhaul of manufacturing rules for Indian Pharma in two decades. It moves the industry from basic […]

Read More

Regulation/Guidelines

Post-Market Surveillance and Pharmacovigilance Compliance Under India’s PvPI Framework

A practical guide to post-market surveillance obligations, adverse event reporting timelines, PSUR filings, and CDSCO enforcement trends under India’s PvPI framework. Getting a Drug approved in India is only half the journey. Post-market surveillance and Pharmacovigilance compliance under India’s PvPI framework continue for the entire lifecycle of the product, not […]

Read More

Regulation/Guidelines

Cosmetic Claims Substantiation: What Counts as Evidence Under Indian Rules

Walk down any Cosmetics aisle and you will see claims like “clinically proven,” “dermatologist tested,” or “reduces fine lines in two weeks.” These claims sell products — but under the Cosmetics Rules, 2020, they also come with legal responsibility. Under Rule 36 of the Cosmetics Rules, 2020, a Cosmetic must […]

Read More
knowledge-service-img

Regulation/Guidelines

CDSCO vs US FDA vs EMA: Why the Same Drug Faces Different Approval Requirements

A practical comparison of CDSCO vs FDA vs EMA, explaining how each regulator’s Drug approval process differs and why one Drug needs separate approvals in India, the US and Europe. A Drug approved in the United States is not automatically approved in India or Europe. Comparing CDSCO vs FDA vs […]

Read More
knowledge-service-img

Regulation/Guidelines

Can You Change Your Authorized Agent in India?

A quick guide on Change Authorized Agent India requirements, the role of a CDSCO Authorized Agent, and how foreign manufacturers manage this transition. Yes, a foreign manufacturer can absolutely change its Authorized Agent India appointment whenever business needs, performance concerns, or compliance requirements make a switch necessary. The process is […]

Read More
knowledge-service-img

Regulation/Guidelines

AI/ML-Based Medical Devices — Emerging Regulatory Questions

Traditional Medical Device regulation assumes a fixed product: what’s approved is what ships, indefinitely, until a formal change is filed and reviewed. Adaptive AI and machine learning algorithms break that assumption by design — a model that continues learning after deployment is, in a meaningful sense, a different product than […]

Read More

Regulation/Guidelines

How to Manufacture Class A & B Medical Devices in India: State FDA License Guide

A quick guide on the Class A & B Medical Device manufacturing license — covering State FDA rules, Form MD-3/MD-5, fees, and timelines for manufacturers. Every manufacturer entering India’s device market must secure a Class A & B Medical Device manufacturing license before commercial production begins. This applies specifically to […]

Regulation/Guidelines

The Cosmeceuticals Grey Zone: When a Cosmetic Claim Risks Becoming a Drug Claim

“Cosmeceutical” is a popular marketing word. It suggests something more powerful than an ordinary Cosmetic — a product that treats skin condition, not just improves appearance. The problem is that Indian law does not recognize “Cosmeceutical” as a regulatory category at all. A product is either a Cosmetic or a […]

Regulation/Guidelines

Ingredient Safety Dossiers: Building a Defensible Package for Novel Actives 

Companies developing Cosmetics with new or unusual active ingredients face a higher regulatory bar in India than those using well-established formulations. Understanding what “new” means under the Cosmetics Rules, 2020, and what needs to go into a safety dossier, can save months of delay at the approval stage.  Step One: Find Out If Your Ingredient Is Actually […]